Spruce Biosciences, Inc.
SPRB
$89.20
$6.097.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -82.23% | -76.48% | -68.44% | -59.77% | -44.41% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -64.94% | -30.76% | -6.48% | -18.03% | -1.08% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 238.95% | 76.22% | 28.00% | 15.65% | 105.25% |
| Total Current Assets | -77.17% | -71.65% | -64.39% | -56.74% | -42.80% |
|
|
|||||
| Total Current Assets | -77.17% | -71.65% | -64.39% | -56.74% | -42.80% |
| Net Property, Plant & Equipment | -26.35% | -24.25% | -22.48% | -20.91% | -19.52% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -88.32% | -88.30% | -63.11% | -88.14% | -12.52% |
| Total Assets | -76.48% | -71.11% | -63.85% | -56.51% | -42.38% |
|
|
|||||
| Total Accounts Payable | -22.96% | 18.33% | -0.63% | -61.13% | -42.93% |
| Total Accrued Expenses | -6.74% | -43.54% | -1.31% | -16.05% | -34.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -55.30% | -34.20% | -13.02% | 1.71% | 1.66% |
| Total Finance Division Other Current Liabilities | -66.86% | -90.06% | -79.71% | -- | -91.06% |
| Total Other Current Liabilities | -66.86% | -90.06% | -79.71% | -- | -91.06% |
| Total Current Liabilities | -20.50% | -43.58% | -14.83% | -37.68% | -50.98% |
|
|
|||||
| Total Current Liabilities | -20.50% | -43.58% | -14.83% | -37.68% | -50.98% |
| Long-Term Debt | -- | -- | -- | -92.78% | -75.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -38.20% | -34.09% | -30.63% | -27.77% | -25.30% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 19.49% | 24.09% |
| Total Liabilities | -26.27% | -47.16% | -21.95% | -40.27% | -51.22% |
|
|
|||||
| Common Stock & APIC | 0.58% | 0.85% | 1.51% | 1.95% | 2.08% |
| Retained Earnings | -21.12% | -22.17% | -26.55% | -26.89% | -21.05% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -89.57% | -77.72% | -77.00% | -62.33% | -39.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -89.57% | -77.72% | -77.00% | -62.33% | -39.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -89.57% | -77.72% | -77.00% | -62.33% | -39.52% |
|
|
|||||